Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1390777 NEW YORK, NY
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$3,114,472
+$1,072,384 QoQ
Shares Held
171,031
+19.0% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#46
of 183 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority Sole 83% Shared 0% None 17%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. CGEM ranks #122 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in CGEM

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,114,472 171,031
2026-03-31 $2,042,088 143,708
2025-12-31 $1,499,992 144,927
2025-09-30 $889,052 149,925
2025-06-30 $1,173,782 155,881
2025-03-31 $1,032,652 136,414
2024-12-31 $1,676,161 137,616
2024-09-30 $2,315,910 138,346
2024-06-30 $2,406,666 137,997
2024-03-31 $1,605,848 94,240
2023-12-31 $1,008,840 99,003
2023-09-30 $879,288 97,159
2023-06-30 $937,948 87,170
2023-03-31 $984,534 96,240
2022-12-31 $1,150,065 109,011
2022-09-30 $1,357,355 105,878
2022-06-30 $1,183,336 92,304
2022-03-31 $975,635 93,184
2021-12-31 $1,472,376 95,423
2021-09-30 $1,809,300 80,164
2021-06-30 $1,020,394 39,627
2021-03-31 $1,451,156 34,825